Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past one year. Pfizer is at the forefront of the
Two areas that provide Pfizer (PFE) with ample opportunity for future growth
Categories
pharmaceuticals
It’s worth keeping an eye on Vertex Pharma (VRTX) stock. Here’s why
After dominating the cystic fibrosis market for quite some time, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is currently expanding its clinical programs to
Will restructuring, cost-cutting help Walgreens (WBA) beat COVID blues?
The growing demand for new therapeutic solutions and advanced research in areas like human-genome will keep the biotechnology industry busy in the
Walgreens Boots Alliance Inc. (WBA) Q2 2021 Earnings Call
Walgreens Boots Alliance Inc. (NASDAQ: WBA) Q2 2021 earnings call dated Mar. 31, 2021 Corporate Participants: Gerald Gradwell — Senior Vice President of Investor Relations
Here’s what you need to know before investing in Amgen (AMGN)
The coronavirus outbreak has made leading pharma companies channelize their resources for vaccine development, and the efforts have been largely successful. While
Walgreens Boots Alliance, Inc. (WBA) Q2 2021 Earnings Call Transcript
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q2 2021 earnings call dated Mar. 31, 2021 Corporate Participants: Gerald Gradwell -- Senior Vice President of Investor
Walgreens Boots Alliance (WBA) Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported second-quarter 2021 earnings results today. Sales increased 4.6% to $32.8 billion. It is up 3.5%
What’s happening on the COVID-19 front? Here are a few updates.
Right about this time last year, the COVID-19 pandemic took over the world with full force as several countries went into complete
These two factors will play out in favor of Pfizer (PFE) going forward
Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past 12 months. The company had a huge win with
Abbott’s (ABT) stock can give high returns, thanks to COVID-related tailwinds
The financial performance of Abbott Laboratories (NYSE: ABT) has been positively impacted by the high demand for COVID-related diagnostic services. However, in
Medtronic (MDT) goes the extra mile to emerge stronger from virus crisis
The pandemic has influenced the healthcare industry significantly, but not all the segments are impacted in the same way. While hospitals and
Solid pipeline makes ImmunoGen (IMGN) a good long-term investment
ImmunoGen Inc. (NASDAQ: IMGN) last week reported a profit after incurring losses in the first three quarters of last year. The surprise
CVS Health Corp. (CVS) Earnings: 4Q20 Key Numbers
CVS Health Corporation (NYSE: CVS) reported fourth quarter 2020 earnings results today. Total revenues increased 4% to $69.5 billion compared to the
Infographic: Highlights of Aurora Cannabis (ACB) Q2 2021 earnings report
Aurora Cannabis, Inc. (NYSE: ACB) on Thursday reported a loss for the second quarter of 2021, continuing the recent trend. However, the
Eylea recovery, COVID antibody cocktail make Regeneron an attractive bet
After last year's mixed performance, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) looks to take advantage of the robust pipeline and the success of
Strong pipeline, M&A synergies to keep Bristol Myers on growth path
Bristol Myers Squibb Company (NYSE: BMY) is thriving on its multi-pronged growth plan, based on strategic acquisitions and the promising pipeline. Recently,
Bristol Myers (BMY) stock gains after Q4 results beat Street view
Bristol-Myers Squibb Company (NYSE: BMY) Thursday reported stronger-than-expected fourth-quarter results. The company's stock gained in the pre-market session soon after the announcement.
Infographic: Highlights of Merck & Co. (MRK)Q4 2020 earnings report
Merck & Co., Inc. (NYSE: MRK) reported weak earnings and sales for the fourth quarter of 2020. Worldwide sales edged up 5%
AbbVie (ABBV) Earnings: 4Q20 Key Numbers
AbbVie Inc. (NYSE: ABBV) reported fourth quarter 2020 earnings results today. Worldwide net revenues rose 59.2% year-over-year to $13.8 billion on a
Pfizer (PFE) Q4 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2020 earnings results today. Revenues increased 12% year-over-year to $11.7 billion. On a GAAP
Infographic: Vertex Pharmaceuticals (VRTX) 4Q20 Earnings Results
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported fourth quarter 2020 earnings results today. Total revenues increased 15% year-over-year to $1.62 billion. GAAP net